Pneumothorax following combination chemotherapy with bevacizumab: A case report and review of the literature

  • Authors:
    • Taha Alrifai
    • Raya Saba
    • Dana Rifai
    • Sarbagya Pandit
    • Kelley E. Kozma
  • View Affiliations

  • Published online on: May 28, 2019     https://doi.org/10.3892/mco.2019.1868
  • Pages: 173-176
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Bevacizumab (BV) is a humanized monoclonal antibody that inhibits angiogenesis by targeting vascular endothelial growth factor (VEGF). The addition of BV to combination chemotherapy has been shown to improve the outcomes in several malignancies, including colorectal carcinoma (CRC). However, the use of BV has been associated with adverse effects, including hypertension, hemorrhage, proteinuria, delayed wound healing and bowel perforation. Pneumothorax (PTX) as an adverse event associated with BV use has rarely been reported. We herein report the case of a 68‑year‑old female patient with a history of metastatic CRC treated with combination chemotherapy, including BV, who presented with complaints of shortness of breath and was found to have a right‑sided PTX.
View Figures
View References

Related Articles

Journal Cover

August-2019
Volume 11 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Alrifai T, Saba R, Rifai D, Pandit S and Kozma KE: Pneumothorax following combination chemotherapy with bevacizumab: A case report and review of the literature. Mol Clin Oncol 11: 173-176, 2019
APA
Alrifai, T., Saba, R., Rifai, D., Pandit, S., & Kozma, K.E. (2019). Pneumothorax following combination chemotherapy with bevacizumab: A case report and review of the literature. Molecular and Clinical Oncology, 11, 173-176. https://doi.org/10.3892/mco.2019.1868
MLA
Alrifai, T., Saba, R., Rifai, D., Pandit, S., Kozma, K. E."Pneumothorax following combination chemotherapy with bevacizumab: A case report and review of the literature". Molecular and Clinical Oncology 11.2 (2019): 173-176.
Chicago
Alrifai, T., Saba, R., Rifai, D., Pandit, S., Kozma, K. E."Pneumothorax following combination chemotherapy with bevacizumab: A case report and review of the literature". Molecular and Clinical Oncology 11, no. 2 (2019): 173-176. https://doi.org/10.3892/mco.2019.1868